Skip to content

Analyzing the effect of Zingiber Officinale on reduction of postoperative pain after hernia and hydrocele operation under general anesthesia

Analyzing the effect of Zingiber Officinale on reduction of postoperative pain after hernia and hydrocele operation under general anesthesia in patients of the Shahrekord Kashani hospital surgery ward

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017051533978N1
Enrollment
90
Registered
2017-10-11
Start date
2017-05-15
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Inguinal hernia. Condition 2: Hydrocele. Unilateral or unspecified inguinal hernia, without obstruction or gangrene Inguinal hernia (unilateral) NOS Hydrocele, unspecified

Interventions

Intervention 1: Zintoma capsule, 250 mg, Gol darou factory, 4 capsules 30 minutes before surgery. Intervention 2: Starch powder capsule, 250 mg, 4 capsules 30 minutes before surgery.
Treatment - Drugs
Placebo
Zintoma capsule, 250 mg, Gol darou factory, 4 capsules 30 minutes before surgery
Starch powder capsule, 250 mg, 4 capsules 30 minutes before surgery

Sponsors

Vice chancellor for research center of Shahrekord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 55 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Elective hydrocele or hernia surgery; surgery duration less than 45 minutes; patients with ASA class I-III; not taking ginger on regular basis; not taking corticosteroids, no allergy to ginger; no allergy to NSAIDS or Acetaminophen; not taking anticoagulatory agents; Exclusion criteria: Surgury duration more than 45 minutes; change in the course of the surgery(complications e.g. bleeding or change of diagnosis e.g. malignancy); no tendency to participate; hematologic or gastrointestinal disorders; substance abuse; any type of fever, infection or disease post surgery.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 30 minutes, 1, 2, 6 , and 24 hours after surgery. Method of measurement: VAS questionnaires.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Lalegani

Shahrekord University of Medical Sciences

ST-lalegani.s@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026